You are here:-Qi Zhong

About Qi Zhong

This author has not yet filled in any details.
So far Qi Zhong has created 6 blog entries.

17th San Diego BioPharma Conference & 6th Pacific Bio-Partnering

17th San Diego BioPharma Conference Program Highlights Ignyta’s unlikely journey in precision medicine: From Dx start-up to global personalized healthcare company A 2018 Breakthrough Prize Winner’s insights on gene silencing therapy An industry veteran’s insights on the trends, gaps and opportunities for delivering innovation to therapeutic application Neurocrine’s

科伦药物研究所高端招聘 (多种岗位,多个位置)(20160613)

Kelun Pharmaceutical is one of China's top-10 pharmaceuticals with R&D branches in US and in China. Kelun Group, a 2015 Fortune 500 company in China, with 30000 staffs in 90+ subsidiaries, is the market leader of injectable and infusion technologies. Kelun Group´s revenues in 2015 >RMB 39 billion, or USD 6 billion. Kelun Pharmaceutical Research

Symposium on advances in heart failure

Heart failure remains a major public health problem in the U.S. despite considerable advances in our understanding of its causes and the development of new approaches for treatment. To meet the substantial challenges posed by the growing heart failure population and improve outcomes in our patients, the 23rd Annual San Diego Heart Failure Symposium has

Protected: 2017 成都海外(生命健康)创新创业大赛公告

This content is password protected. To view it please enter your password below: Password:

Meet Janssen China Development leadership team in La Jolla

Today, China is facing a wide array of complex and unmet medical needs. As a global healthcare leader, Janssen, Pharmaceutical Companies of Johnson & Johnson, has an important role to play in addressing these significant medical needs and creating value through innovation in R&D and medical science. China is critical in setting pace for worldwide

17th SABPA Education & Career Development (ECD) Workshop